Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga Insights

TherapeuticsMD: Q1 Earnings Insights

TherapeuticsMD (NASDAQ:TXMD) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


TherapeuticsMD missed estimated earnings by 18.0%, reporting an EPS of $-4.72 versus an estimate of $-4.0.

Revenue was down $533.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 0.0% increase in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.08 -0.10 -0.11 -0.12
EPS Actual -0.09 -0.11 -0.11 -0.11
Revenue Estimate 29.39M 25.87M 22.11M 19.77M
Revenue Actual 18.68M 25.41M 23.00M 19.87M

To track all earnings releases for TherapeuticsMD visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.